Plain-English translation of NCT06511141 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Axonics sacral neuromodulation system, a small implanted device that sends gentle electrical signals to nerves that control your bladder. The study aims to see how well this treatment works for men who have had prostate cancer surgery, radiation, or prostate enlargement surgery and are now struggling with an overactive bladder. Researchers want to understand whether this device can reduce urgent bathroom trips and accidents in this specific group of patients.
Many men who undergo prostate treatment develop overactive bladder symptoms that can significantly affect their quality of life. This trial exists to determine whether this nerve stimulation treatment can safely and effectively help these patients regain better bladder control.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive the Axonics sacral neuromodulation device, which is surgically implanted to stimulate the nerves that control your bladder. You will then visit the clinic regularly over one year to have your symptoms monitored, complete questionnaires about your bladder function, and keep bladder diaries to track your progress. The research team will check how well the device is working and adjust it as needed to help improve your bladder control.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States